Phenotypic Clusters and Sacubitril/Valsartan in Heart Failure with PreservedEjec on Frac on: A PARAGON-HF Substudy
by Prateek Chopra | May 18, 2026 | Cardiology Conferences | ESC-HF 2026 Heart Failure with preserved ejection fraction (HFpEF) is a clinically heterogeneous syndrome with substantial variability in patient characteristics, prognosis, and therapeutic response. Despite advances in HF management, treatment outcomes in HFpEF remain inconsistent, likely reflecting differences in underlying pathophysiological mechanisms across patient subgroups. Machine learning–based phenotyping has emerged […]